An Observational Study to Learn More About Treatment With Regorafenib in People With Advanced Gastrointestinal Stromal Tumors in the United States

Conditions: Advanced Gastrointestinal Stromal Tumor Interventions: Drug: Regorafenib (Stivarga, BAY73-4506) Sponsors: Bayer Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials